• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Acadia Pharmaceuticals - Articles and news items


FDA approves Nuplazid to treat hallucinations in Parkinson’s disease

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

The FDA has approved Acadia’s Nuplazid, the first drug approved to treat hallucinations and delusions experienced by some people with Parkinson’s disease…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +